A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight

Conditions:   Overweight;   Obesity Interventions:   Drug: ADF1 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 75mg;   Drug: ADF2 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 100mg;   Drug: SIB Group Sibus (Sibutramine) 15mg;   Drug: Placebo Group Sponsor:   Eurofarma Laboratorios S.A. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials